Jie Ren

Jie Ren


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 October 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
JRJie Ren
Jie Ren
JRJie Ren
Jie Ren
Background and objective: Uveitis is a group of immune-mediated inflammatory diseases of the eye and remains one of the leading causes of preventable visual loss in working-age adults, with relapsing and treatment-refractory phenotypes closely tied to disturbed peripheral myeloid immune homeostasis. Conventional type 2 dendritic cells (CD1c+ cDC2) sit at the junction between JAK-STAT cytokine signaling and antigen presentation, yet systematic work that quantifies this axis into a reproducible, falsifiable, and explicitly evidence-graded candidate set remains scarce. The present study therefore set out to decode the molecular pattern of the JAK-STAT axis in peripheral blood CD1c+ cDC2 cells from patients with uveitis and, while explicitly annotating the strength of each layer of evidence, to prioritize a candidate-target panel that can guide subsequent wet-laboratory work. Methods: With GEO dataset GSE194060 (28 uveitis and 14 healthy-control samples of sorted CD1c+ cDC2 cells) as the discovery cohort and the 168 genes of KEGG hsa04630 (JAK-STAT signaling) as a fixed molecular axis, we deployed an end-to-end pipeline: differential expression and three-way intersection (expression layer) → cis-instrument inverse-variance weighted (IVW) Mendelian randomization with FinnGen R12 iridocyclitis as the outcome (genetic-association layer) → consensus clustering and immune-microenvironment profiling → candidate locking by the intersection of LASSO, random forest, and SVM-RFE (machine-learning layer) → multi-cohort single-gene diagnostic modeling of STAM2 → aqueous-humor single-cell atlas and cell-cell communication → myeloid pseudotime and computational perturbation → qPCR, DrugReflector active-learning virtual screening, and molecular docking. Each layer was reported against its prespecified thresholds; the primary DrugReflector signature was evaluated by 200 sample-level bootstrap resamples, Mendelian randomization by leave-one-out analysis, and the remaining layers by the sensitivity analyses prespecified for each layer. Results: At the expression level, 3,301 nominally differential genes, the 168 JAK-STAT axis genes, and 3,872 uveitis-associated genes converged on an 18-gene intersection that included IL10 and PDGFB. At the genetic-association level, IVW analysis identified 20 genes at nominal significance (p< 0.05), 8 of which passed Benjamini-Hochberg FDR (q< 0.05); IL10 (q= 0.1246), STAM2 (q= 0.1246), and PDGFB (q= 0.1573) reached nominal significance only, without passing FDR correction, and are reported as nominal associations. The intersection of the three machine-learning algorithms converged on the three transcripts IL10 / PDGFB / STAM2. A STAM2 single-gene diagnostic model reached an AUC of 0.7883 in the training cohort and 0.8056 and 0.8000 in two independent myeloid/monocyte cohorts (a same-study audit cohort yielded 0.6288 and is used for sensitivity analysis only). The aqueous-humor single-cell atlas resolved 37,664 cells, 18 clusters, and 20 cell types; STAM2 myeloid pseudotime identified four differentiation states; and computational perturbation placed STAM2 among the most sensitive nodes (|Z|=5.17). DrugReflector active learning identified a single compound, BRD-K11973162 (probability 0.1591), exceeding the prespecified reversal-probability threshold of 0.10 among 9,597 compounds. In the LPS-stimulated THP-1 myeloid inflammation model, qPCR showed significant up-regulation of all three candidates relative to unstimulated controls (IL10, 1.5365-fold, p=3.17×10⁻³; PDGFB, 1.6592-fold, p=4.76×10⁻⁵; STAM2, 1.8220-fold, p=1.95×10⁻⁵; n=3 per group, n=3+3 total). Conclusion: In uveitis peripheral CD1c+ cDC2 cells, this study delineates a JAK-STAT-centered IL10–PDGFB–STAM2 candidate panel defined by an integrated chain of expression, genetic-association, machine-learning, single-cell, and in vitro evidence, and proposes...

2 October 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
JRJie Ren
Jie Ren
JRJie Ren
Jie Ren
Background: Short sleep and depression frequently co-occur in older adults, but whether they share a gut microbiota signature or carry largely phenotype-specific features remains unresolved. We therefore characterized fecal microbiota features shared by or specific to short sleep and depression using American Gut Project 16S rRNA data. Methods: Using American Gut Project (AGP) V4 16S rRNA data (PRJEB11419), we assigned older adults to four mutually exclusive groups: healthy controls (HC; 7-8 h sleep, no depression), short-sleep only (SSD), depression only (DP), and short-sleep plus depression (SSD + DP; exploratory). Complete age, sex, and BMI data with at least 1,000 reads yielded 1,056 participants (HC 617; SSD 255; DP 148; SSD + DP 36). We examined diversity, taxonomy, covariate-adjusted genus-level associations, and cross-validated discrimination. Scale-upgraded sensitivity analyses included 1,307 participants, 146 genera, and 20 multiply imputed data sets. Results: Richness (q = 0.001; adjusted q = 0.007), Shannon diversity (q = 0.031; adjusted q = 0.111), and Faith's diversity (q = 0.001; adjusted q = 0.007) differed across groups; adjusted richness and Faith's diversity also differed among depression-only participants (both q = 0.003). PERMANOVA showed no global separation (minimum P = 0.065). Significant genera numbered 3 in SSD, 3 in DP, and 0 in SSD + DP: SSD was associated with UCG-002 (log2FC = -1.01), UCG-003 (-0.76), and Erysipelatoclostridium (+0.69), and DP with UCG-003 (-1.21), [Ruminococcus] gnavus group (+1.06), and Lachnospiraceae UCG-010 (-0.71). Core clinical AUCs were 0.554 (95% CI 0.514-0.596) and 0.623 (0.579-0.668), rising to 0.599 (0.559-0.640) and 0.654 (0.611-0.695) with extended clinical variables; adding microbiota features lowered these to 0.566 (0.524-0.608) and 0.637 (0.593-0.680), providing no gain. Sensitivity AUCs were 0.575-0.610 and 0.643-0.675. Scale-upgraded OLS/limma confirmed 17 genera and 8 interaction genera, with AUCs of 0.585 and 0.645; additional models reached 0.622 and 0.687. A phenotype-matched constipation contrast (78 cases, 695 controls) yielded AUCs of 0.771 and 0.798. Conclusion: Short sleep and depression showed modest, largely non-overlapping microbiota signals, whereas constipation showed a clearer but still non-diagnostic signal. These findings are hypothesis-generating and do not support clinical or causal interpretation.

19 October 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
JRJie Ren
Jie Ren
JRJie Ren
Jie Ren
Background. Hospitalisation in later life frequently occurs during a period of functional vulnerability. Socioeconomic differences in subsequent change in activities of daily living (ADL) may help identify groups that need closer follow-up, but reported associations can depend on which health and functional characteristics are adjusted for. We examined whether education and household wealth were associated with ADL deterioration and whether these associations were stable across successively adjusted models in two health-system contexts. Methods. We analysed the Health and Retirement Study (HRS; waves 13-15, 2016-2020) and the China Health and Retirement Longitudinal Study (CHARLS; waves 2-4, 2013-2018) as two parallel cohorts. Eligible respondents were aged 50 years or older, reported hospitalisation between the baseline and follow-up waves, and had ADL measured at both waves. ADL deterioration was defined as a higher ADL difficulty count at follow-up than at baseline. A fixed nested sequence was used: age and sex plus education and wealth; addition of marital status, chronic conditions and depressive symptoms; and further addition of baseline ADL and IADL difficulty. Sensitivity analyses included respondent weighting, alternative outcome definitions, multiple imputation, expanded wealth imputation, death-inclusive models and E-values. Results. ADL deterioration occurred in 604 of 2,892 HRS respondents with an observed outcome (20.9%) and 454 of 1,691 CHARLS respondents with an observed outcome (26.8%). In HRS, the wealth OR moved from 0.788 (95% CI 0.718-0.866) in the socioeconomic model to 0.847 (0.765-0.938) after clinical adjustment and 0.857 (0.773-0.950) after further adjustment for baseline function. The education OR was 0.944 (0.916-0.973), 0.949 (0.920-0.979) and 0.947 (0.917-0.977), respectively. In CHARLS, the wealth OR was 0.827 (0.708-0.965; p = 0.016) before clinical adjustment, 0.855 (0.730-1.001; p = 0.051) after clinical adjustment and 0.853 (0.727-1.002; p = 0.053) after further adjustment for baseline function. Respondent-weighted multiple-imputation and community-cluster estimates in CHARLS remained compatible with no association (0.892, 95% CI 0.744-1.070; expanded wealth imputation 0.896, 0.777-1.034). CHARLS education estimates were too imprecise to support a gradient. Conclusions. Socioeconomic associations with ADL deterioration were not equivalently robust across cohorts. HRS showed an inverse wealth association across the nested models, whereas the CHARLS wealth signal weakened mainly with clinical adjustment and was not stable under missing-data and weighting scenarios. Most attenuation occurred at the clinical-covariate step, not after adding baseline function. These results argue for reporting model dependence and cohort heterogeneity explicitly; they do not establish a universal socioeconomic gradient, causality or clinical prediction.


9 October 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
JRJie Ren
Jie Ren
JRJie Ren
Jie Ren
Background: Abdominal aortic aneurysm (AAA) is characterised by irreversible dilatation of the abdominal aorta and a risk of rupture. Clinical assessment still relies mainly on diameter and growth rate and does not capture the immune, vascular and matrix heterogeneity of the aortic wall. Protein S-palmitoylation is catalysed by ZDHHC palmitoyltransferases and reversed by depalmitoylating enzymes. It regulates membrane localisation and trafficking of immune receptors, chemokine receptors, ion channels and vascular signalling proteins. However, whether palmitoylation-related machinery and substrates jointly define an AAA disease axis has not been systematically examined. This study aimed to identify a reproducible palmitoylation-related module in human AAA tissue, to screen axis-level cis-eQTL multiplicity-controlled significant genes and to independently define the strict genetic effect boundaries of that module at a cis-eQTL layer, to converge the module onto core targets using multi-omics, machine learning, single-cell analysis and computational docking, and to validate the hub genes at the tissue-expression level by real qPCR. Methods: We used GSE232911 (110 patients with AAA and 13 donors) as the discovery cohort and assembled an S-palmitoylation machinery-and-substrate axis gene set. A tissue-level module was frozen from the intersection of differential expression, the axis gene set and pre-specified AAA vascular and inflammatory programmes. We then performed axis-level cis-eQTL Mendelian randomisation (MR) screening with Benjamini-Hochberg FDR and Bonferroni double correction to select multiplicity-controlled significant genes, together with independent validation at a strict cis-eQTL layer with coloc.abf colocalisation; disease-internal consensus clustering; LASSO, random forest and SVM-RFE feature selection within the frozen module; a single-gene logistic model with two external directional checks; construction of the GSE166676 single-cell atlas; myeloid monocle3 trajectory and scTenifoldKnk in-silico perturbation; L1000CDS2, CTD, P2Rank and AutoDock Vina public-resource integration and computational docking; and real qPCR validation of CD80 and HTR2B. Results: The discovery cohort yielded 3,100 differentially expressed genes. The frozen three-way intersection produced a 15-gene module, including 12 up-regulated and 3 down-regulated genes. In the axis-level cis-eQTL screening layer, 161 of the 341 axis genes were estimable, and 42 reached nominal significance (IVW random-effects p<0.05); after Benjamini-Hochberg FDR and Bonferroni double correction, 9 genes simultaneously satisfied q<0.01 and p<0.05/161 and constitute the multiplicity-controlled significant genes: SORT1, BAALC, ZDHHC6, MICA, CD7, CANX, PI4K2A, GSDMD and ADORA2B (five risk-increasing and four risk-decreasing, all p<0.001). In the independent strict cis-eQTL layer (341 axis genes, 35 passing the r²<0.001 instrument gate, 15 estimable), ENTPD1 (OR 0.884, 95% CI 0.790-0.989, p=0.031) and NOD2 (OR 0.942, 95% CI 0.888-0.998, p=0.042) reached nominal significance but none passed BH-FDR<0.05 (minimum q=0.317); single-SNP and leave-one-out analyses quantified the instrument-contribution boundaries of the two signals. None of 106 coloc.abf tests showed strong colocalisation, and the outcome-region audit showed limited AAA GWAS signal in the relevant windows (Figure S1 ). AAA tissue resolved into K=3 disease-internal molecular groups (C1=40, C2=55 and C3=15). The three machine-learning methods uniquely converged on CD80 and HTR2B. The single-gene CD80 model had a training AUC of 0.9685 and remained directionally consistent in two external cohorts (AUC 0.7551 and 0.7449). The single-cell atlas retained 7,596 cells, and the myeloid perturbation converged on cytokine-cytokine receptor interaction (KEGG, k=9/50, FDR=0.00355). The druggability layer returned 38 unique perturbagens, 29 high-evidence CD80-related compounds and computational docking for both targets; the best mode-1 affinities were -7.46 kcal/mol for CD80 and -8.98 kcal/mol for HTR2B. Real qPCR showed higher CD80 (1.54-fold, p=0.0032) and HTR2B (1.66-fold, p=4.8x10^-5) expression in AAA tissue than in donor tissue. Conclusion: We delineate an S-palmitoylation-contextualised immune-vascular disease axis in human AAA and place CD80 and HTR2B at the intersection of multi-omics screening, computational perturbation, computational docking and real qPCR tissue validation. The genetic layer returned nine multiplicity-controlled significant genes at the axis-level screen and retained two nominal associations with their full correction boundaries at the independent strict layer. The single-cell, perturbation and docking layers provide mechanistic and druggability directions, and qPCR provides expression-level validation in human aortic tissue. Collectively, the evidence supports a testable palmitoylation-immune costimulation-vascular inflammation axis and establishes an executable framework for functional and cohort validation.